DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactStocks

Stocks to watch out for today, October 21: Infosys, Ceigall, Dhampur Bio, JSW Dulux, Venus Pipes, Transrail, Orchid Pharma among 15 stocks in focus

BusinessLine 1 hr ago·21 Oct 2026, 2:23 am

Orchid Pharma is in focus today as investors monitor the company's upcoming quarterly results. The stock is likely to see volatility based on the numbers it reports, which will provide insight into the company's current financial health and operational performance.

For investors, this earnings release is a key event to assess the firm's growth trajectory and profitability. The market will be watching for guidance on future business prospects, which could influence the stock's direction in the short term.

Investors should pay close attention to the management commentary regarding the company's strategy and any updates on its ongoing projects or regulatory matters.